Rising Cancer Prevalence Fueling The Growth Of The Market Due To Increasing Demand For Targeted And Personalized Treatment Solutions Is Supporting Development Across The Genetic Analysis Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Estimated Growth In Market Size Of The Genetic Analysis Market During 2026–2030?

The genetic analysis market size has experienced rapid growth in recent years. This market is set to expand from $10.29 billion in 2025 to $11.63 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.0%. The historical increase can be ascribed to factors including the limited provision of high-throughput sequencing platforms, the reliance on traditional genetic testing methods, increasing public knowledge of genetic disorders, greater investment in research laboratories, and a rising number of diagnostic centers.

The genetic analysis market is poised for significant expansion in the coming years, with projections indicating it will reach $18.75 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.7%. This growth trajectory during the forecast period is primarily attributed to advancements in ngs and real-time pcr technologies, the development of cloud-based genomic data platforms, the increasing adoption of personalized medicine, escalating government initiatives for genetic disease screening, and the integration of ai and bioinformatics tools into diagnostics. Prominent trends anticipated within this period include the broadening of ngs and pcr-based genetic testing, the rising acceptance of pharmacogenomic testing for tailored medicine, an increase in prenatal and newborn genetic screening programs, a heightened focus on rare disease and cancer genetic diagnostics, and the integration of bioinformatics and genomic data analysis tools.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27295&type=smp

Which Growth Drivers Are Expected To Support The Genetic Analysis Market Forward?

The genetic analysis market is anticipated to experience growth due to the escalating number of cancer cases. Cancer is defined as a condition where specific cells within the body multiply uncontrollably and have the potential to spread to other areas. The rise in cancer incidents stems from an aging global populace, as older individuals are more susceptible to accumulating genetic mutations and prolonged exposure to environmental and lifestyle factors contributing to cancer development. Genetic analysis offers benefits in cancer management by detecting the precise genetic mutations responsible for the disease, thereby empowering doctors to select targeted treatments that prove more effective while causing fewer side effects. For example, a report released by the National Cancer Institute (NCI), a US-based agency focused on cancer research and training, noted that in May 2025, nearly 20 million people worldwide were newly diagnosed with cancer in 2022, and approximately 9.7 million perished from it. Furthermore, estimates suggest that by 2050, the annual total of new cancer diagnoses could reach 33 million, with cancer-related deaths projected to increase to 18.2 million. Hence, the increasing prevalence of cancer is a key driver for the expansion of the genetic analysis market.

Which Segment Groups Define The Genetic Analysis Market Landscape?

The genetic analysis market covered in this report is segmented –

1) By Product: Reagents And Kits, Instruments, Software

2) By Test: Predictive Genetic Testing, Carrier Testing, Prenatal And Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing, Other Tests

3) By Technology: Next-Generation Sequencing (NGS), Real-Time PCR System, Other Technologies

4) By Application: Cancer, Genetic Diseases, Cardiovascular Diseases, Rare Diseases, Infectious Diseases, Other Applications

5) By End-Use: Hospitals, Research And Development Laboratories, Diagnostic Centers, Other End-Uses

Subsegments:

1) By Reagents And Kits: DNA Extraction Kits, RNA Extraction Kits, PCR Reagents, Sequencing Reagents, Library Preparation Kits, Electrophoresis Reagents, Microarray Kits, Genotyping Assay Kits, Target Enrichment Kits, Nucleic Acid Labeling Kits

2) By Instruments: DNA Sequencers, PCR Machines, Microarray Scanners, Electrophoresis Systems, Real-Time PCR Systems, Automated Sample Preparation Systems, Genetic Analyzers, Bioanalyzers, Fragment Analyzers, Next-Generation Sequencing (NGS) Platforms

3) By Software: Data Analysis Software, Bioinformatics Tools, Laboratory Information Management Systems (LIMS), Genomic Data Interpretation Software, DNA Sequence Alignment Tools, Variant Annotation Software, Clinical Decision Support Software, Cloud-Based Genomic Platforms, Workflow Management Software, Data Visualization Tools

What Trends Are Influencing The Genetic Analysis Market?

Major companies operating in the genetic analysis market are concentrating on developing sophisticated offerings, such as genetic testing solutions, for preventive measures or early disease monitoring. Genetic testing solutions involve evaluating a person’s DNA to identify changes or variations in genes that might be linked to particular health conditions or inherited traits. For instance, in June 2023, Devyser, a Sweden-based company specializing in diagnostic kit development, launched Devyser LynchFAP and Devyser BRCA PALB2, two genetic testing solutions for hereditary cancer. Devyser LynchFAP provides a complete solution for analyzing PMS2 and nine additional genes associated with hereditary colorectal cancer, effectively addressing the complex challenge of distinguishing PMS2 from its pseudogene PMS2CL. It is the first commercial kit specifically created for precise analysis of the PMS2 gene. Devyser BRCA PALB2 enables targeted detection of genetic variants in BRCA1, BRCA2, and PALB2, which are key genes linked to an increased risk of breast and ovarian cancer. Its user-friendly interface allows for quick integration into lab workflows and supports DNA analysis from both blood and tumor samples within a single test.

Which Organizations Are Involved In The Genetic Analysis Market?

Major companies operating in the genetic analysis market are Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Quest Diagnostics Inc., Illumina Inc., PerkinElmer Inc., BioRad Laboratories Inc., Qiagen NV, Oxford Nanopore Technologies Plc, 23andMe Inc., ELITech Group, MyHeritage Ltd., Dante Labs Inc., AutoGenomics Inc., IntegraGen SA, Family Tree DNA, 24 genetics, Centrillion Biosciences Inc., DNA Worldwide Group Ltd., Genebase.

Access The Complete Genetic Analysis Market Report:

https://www.thebusinessresearchcompany.com/report/genetic-analysis-global-market-report

Which Region Is The Dominant Market In The Genetic Analysis Market?

North America was the largest region in the genetic analysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Genetic Analysis Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=27295&type=smp

Browse Through More Reports Similar to the Global Genetic Analysis Market 2026, By The Business Research Company

Scanner Market Report 2026

https://www.thebusinessresearchcompany.com/report/scanner-global-market-report

Scanner Software Market Report 2026

https://www.thebusinessresearchcompany.com/report/scanner-software-global-market-report

Document Scanning Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/document-scanning-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795